Table 2.
Prevalence of all-cause dementia. Distribution by age and clinical characteristics and in-hospital outcomes among men and women hospitalized with type 2 diabetes in Spain, 2011–2020.
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | p-Value Trend | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | N, prevalence | 12,382 (4.91) | 12,904 (4.94) | 12,854 (4.76) | 13,535 (4.82) | 14,455 (4.93) | 18,969 (6.85) | 22,561 (7.32) | 24,275 (7.39) | 25,337 (7.51) | 25,754 (8.4) | <0.001 |
| Age, mean (SD) | 80.93 (6.74) | 81.08 (6.68) | 81.17 (6.68) | 81.35 (6.76) | 81.56 (6.84) | 81.41 (7.18) | 81.63 (7.26) | 81.69 (7.3) | 81.69 (7.43) | 81.53 (7.5) | <0.001 | |
| 60–69 years, n (%) | 775 (6.26) | 792 (6.14) | 760 (5.91) | 820 (6.06) | 844 (5.84) | 1319 (6.95) | 1557 (6.9) | 1627 (6.7) | 1694 (6.69) | 1865 (7.24) | <0.001 | |
| 70–79 years, n (%) | 4025 (32.51) | 4083 (31.64) | 3991 (31.05) | 3945 (29.15) | 4051 (28.02) | 5288 (27.88) | 6058 (26.85) | 6550 (26.98) | 7345 (28.99) | 7607 (29.54) | <0.001 | |
| ≥80 years, n (%) | 7582 (61.23) | 8029 (62.22) | 8103 (63.04) | 8770 (64.79) | 9560 (66.14) | 12,362 (65.17) | 14,946 (66.25) | 16,098 (66.32) | 16,298 (64.32) | 16,282 (63.22) | <0.001 | |
| CCI, mean (SD) | 1.09 (0.98) | 1.1 (0.98) | 1.12 (0.99) | 1.1 (0.98) | 1.11 (0.99) | 1.3 (1.09) | 1.31 (1.08) | 1.33 (1.1) | 1.38 (1.11) | 1.35 (1.11) | <0.001 | |
| COVID-19, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (0.01) | 3360 (13.05) | <0.001 | |
| IHM, n (%) | 1985 (16.03) | 2015 (15.62) | 1992 (15.5) | 1996 (14.75) | 2278 (15.76) | 3000 (15.82) | 3671 (16.27) | 3949 (16.27) | 4154 (16.39) | 5142 (19.97) | <0.001 | |
| Women | N, prevalence | 20,130 (9.19) | 21,162 (9.46) | 20,293 (8.96) | 21,082 (9.07) | 22,394 (9.36) | 25,597 (11.57) | 29,444 (12.16) | 30,733 (12.28) | 32,017 (12.61) | 30,655 (13.59) | <0.001 |
| Age, mean (SD) | 83.7 (6.31) | 83.83 (6.3) | 84 (6.27) | 84.08 (6.24) | 84.38 (6.28) | 84.31 (6.46) | 84.56 (6.51) | 84.68 (6.59) | 84.79 (6.68) | 84.68 (6.78) | <0.001 | |
| 60–69 years, n (%) | 439 (2.18) | 471 (2.23) | 452 (2.23) | 474 (2.25) | 494 (2.21) | 660 (2.58) | 746 (2.53) | 768 (2.5) | 813 (2.54) | 825 (2.69) | <0.001 | |
| 70–79 years, n (%) | 4354 (21.63) | 4422 (20.9) | 3967 (19.55) | 3888 (18.44) | 3919 (17.5) | 4500 (17.58) | 4829 (16.4) | 5110 (16.63) | 5464 (17.07) | 5525 (18.02) | <0.001 | |
| ≥80 years, n (%) | 15,337 (76.19) | 16,269 (76.88) | 15,874 (78.22) | 16,720 (79.31) | 17,981 (80.29) | 20,437 (79.84) | 23,869 (81.07) | 24,855 (80.87) | 25,740 (80.39) | 24,305 (79.29) | <0.001 | |
| CCI, mean (SD) | 0.79 (0.86) | 0.81 (0.87) | 0.85 (0.88) | 0.84 (0.88) | 0.82 (0.88) | 0.93 (0.94) | 0.97 (0.95) | 0.98 (0.96) | 1.03 (0.98) | 1.01 (0.97) | <0.001 | |
| COVID-19, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0) | 2 (0.01) | 3 (0.01) | 3 (0.01) | 3525 (11.5) | <0.001 | |
| IHM, n (%) | 2972 (14.76) | 3180 (15.03) | 2850 (14.04) | 2979 (14.13) | 3313 (14.79) | 3599 (14.06) | 4356 (14.79) | 4666 (15.18) | 4806 (15.01) | 5418 (17.67) | <0.001 |
CCI: Charlson Comorbidity Index. IHM: In-hospital mortality.